Cellectis SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA with three other
companies in this sector in France:
sales of 25.45 million Euro [US$28.22 million]
(20.09 million Euro [US$22.27 million]
Ose Immunotherapeutics SA
(24.46 million Euro [US$27.11 million]
Cellectis SA reported sales of 18.19 million Euro (US$20.17 million)
December of 2018.
decrease of 38.5%
versus 2017, when the company's sales were 29.60 million Euro.
Contributing to the drop in overall sales was the 56.2% decline
in Plants, from 802,364.04 Euro to 351,365.94 Euro.
There were also decreases in sales in
Therapeutics (down 42.9% to 17.84 million Euro)